The University of California San Diego performance-based skills assessment: a useful tool to detect mild everyday functioning difficulties in HIV-infected patients with very good immunological condition.
Activities of Daily Living
/ psychology
Anti-HIV Agents
/ therapeutic use
Antiretroviral Therapy, Highly Active
Attention
/ physiology
CD4-Positive T-Lymphocytes
/ immunology
Case-Control Studies
Cognition
Cognitive Dysfunction
/ drug therapy
Executive Function
/ physiology
Female
HIV Infections
/ drug therapy
HIV-1
/ immunology
Humans
Male
Memory
/ physiology
Middle Aged
Neuropsychological Tests
Psychiatric Status Rating Scales
Psychomotor Performance
/ physiology
Speech
/ physiology
Cognition evaluation
Everyday functioning
Functional assessment
HIV-associated neurocognitive disorders
Journal
Journal of neurovirology
ISSN: 1538-2443
Titre abrégé: J Neurovirol
Pays: United States
ID NLM: 9508123
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
received:
06
06
2020
accepted:
04
08
2020
revised:
29
07
2020
pubmed:
26
8
2020
medline:
30
10
2021
entrez:
26
8
2020
Statut:
ppublish
Résumé
Everyday functioning (EF) impairment is frequent in people living with HIV (PLWH). Our aim was to better explore EF and its association with PLWH cognition, by administering both the IADL scale, the most common functional scale, and a new and ecologic multi-domain (communication and financial skills) tool to measure EF as the University of California San Diego (UCSD) Performance-Based Skills Assessment-Brief Version (UPSA-B). Eighty-five PLWH on cART with very good immunological condition and 23 age- and education-matched healthy controls (HC) were enrolled. PLWH underwent a standardized neuropsychological battery plus IADL, and cognitive impairment was defined according to Frascati criteria. Both groups underwent the UPSA-B. Only 6 subjects (7%) were affected by cognitive impairment (asymptomatic profile). While IADL score was at ceiling for all patients, the UPSA-B total score was significantly worse in PLWH when compared with HC [mean 82.1 (SD 9.3) vs 89.2 (SD 6.2); p < 0.001]. At communication subtest, PLWH group and HC were significantly different (p = 0.002), while no difference emerged at financial skills (p = 0.096). Higher score at UPSA-B was independently associated with better global cognitive performance (composite Z-score) (β 7.79; p < 0.001). Also considering each single cognitive domain, UPSA-B performance (both total and at subtests) confirmed the association with neurocognitive performance. In conclusion, UPSA-B seems to better discriminate EF impairment than IADL in PLWH, and it was associated with cognitive functions, also in the absence of symptomatic cognitive impairment. Thus, it appears a promising tool in the context of HIV infection to avoid misdiagnosis and to better detect also mild EF.
Identifiants
pubmed: 32839950
doi: 10.1007/s13365-020-00891-8
pii: 10.1007/s13365-020-00891-8
pmc: PMC7716816
doi:
Substances chimiques
Anti-HIV Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
899-907Références
Appl Neuropsychol Adult. 2018 Nov-Dec;25(6):543-554
pubmed: 28742398
Infection. 2020 Feb;48(1):37-42
pubmed: 31691905
J Int Neuropsychol Soc. 1999 Nov;5(7):579-92
pubmed: 10645701
Clin Neuropsychol. 2012;26(6):894-908
pubmed: 22708483
J Clin Exp Neuropsychol. 2011 Feb;33(2):200-9
pubmed: 20694873
AIDS. 2007 Sep 12;21(14):1915-21
pubmed: 17721099
Neurology. 2010 Dec 7;75(23):2087-96
pubmed: 21135382
J Acquir Immune Defic Syndr. 2017 Oct 1;76(2):219-224
pubmed: 28902679
Neurology. 2016 Jan 26;86(4):334-40
pubmed: 26718568
Arch Gen Psychiatry. 1965 Jan;12:63-70
pubmed: 14221692
J Neurovirol. 2011 Feb;17(1):3-16
pubmed: 21174240
Clin Neuropsychol. 2016 Jan-Dec;30(sup1):1457-1468
pubmed: 27180611
J Clin Exp Neuropsychol. 1997 Dec;19(6):795-809
pubmed: 9524875
Antivir Ther. 2013;18(2):153-60
pubmed: 23486721
Schizophr Bull. 2007 Nov;33(6):1364-72
pubmed: 17341468
J Neurovirol. 2017 Feb;23(1):67-78
pubmed: 27557777
J Int Neuropsychol Soc. 2004 May;10(3):317-31
pubmed: 15147590
Neurology. 2007 Oct 30;69(18):1789-99
pubmed: 17914061
Arch Clin Neuropsychol. 2012 Aug;27(5):520-31
pubmed: 22705481
Gerontologist. 1969 Autumn;9(3):179-86
pubmed: 5349366
Arch Clin Neuropsychol. 2018 Mar 1;33(2):184-193
pubmed: 28655206
J Acquir Immune Defic Syndr. 2010 Nov;55(3):411-2
pubmed: 20948386
Schizophr Bull. 2001;27(2):235-45
pubmed: 11354591
J Neurovirol. 2019 Dec;25(6):866-873
pubmed: 31281946
Neuropsychology. 2011 Jul;25(4):511-9
pubmed: 21401259
AIDS. 2010 Jun 1;24(9):1243-50
pubmed: 19996937
Antivir Ther. 2015;20(4):441-7
pubmed: 25516553
Neuropsychol Rev. 2009 Jun;19(2):186-203
pubmed: 19472057
J Neurovirol. 2016 Oct;22(5):575-583
pubmed: 26965299
Eur Neurol. 1996;36(6):378-84
pubmed: 8954307
Eur J Neurol. 2011 Mar;18(3):527-34
pubmed: 21159073
Am J Public Health. 2013 Oct;103 Suppl 1:S122-32
pubmed: 23927543
Am J Psychiatry. 2010 Jul;167(7):845-53
pubmed: 20360320
Infection. 2019 Aug;47(4):589-593
pubmed: 30784024
Arch Clin Neuropsychol. 2014 Dec;29(8):818-27
pubmed: 25404005
Disabil Rehabil. 2012;34(1):19-25
pubmed: 21870997
J Clin Exp Neuropsychol. 2007 Apr;29(3):266-76
pubmed: 17454347
J Addict Med. 2013 Jul-Aug;7(4):255-63
pubmed: 23648641
PLoS One. 2017 Aug 24;12(8):e0183614
pubmed: 28837678